围绕「积雪草苷」与「抗皱」，本页收录 8 篇公开发表的学术文献（2011–2025 年）：5 篇结论不一，1 篇未提供该指标的支持性数据，2 篇仅涉及作用机制。以上为各原研究作者的结论，本平台不作再评价。
归类针对的是「单篇文献对某一项具体指标是否给出支持性数据」，不是对本成分的评价；结论均为原研究作者观点。
摘要显示积雪草苷传递体促进成纤维细胞增殖和胶原产生，但未直接测量抗皱功效，且抗皱仅通过胶原间接推断。
The abstract showed that asiaticoside transfersomes promoted fibroblast proliferation and collagen production, but did not directly measure anti-wrinkle efficacy, and anti-wrinkle was only indirectly inferred from collagen.
摘要显示含积雪草苷的水凝胶促进胶原生物合成，但研究为复合制剂，混杂其他活性成分，且未直接测量抗皱功效。
The abstract showed that asiaticoside-containing hydrogel promoted collagen biosynthesis, but the study was a composite formulation with other active ingredients, and did not directly measure anti-wrinkle efficacy.
摘要显示积雪草苷预处理抑制UVB诱导的MMP生成并增加细胞内胶原水平，但未直接测量皱纹改善，且抗皱功效仅通过胶原和MMP间接推断。
The abstract showed that asiaticoside pretreatment inhibited UVB-induced MMP production and increased intracellular collagen levels, but did not directly measure wrinkle improvement, and anti-wrinkle efficacy was only indirectly inferred from collagen and MMP.
摘要显示积雪草苷涂层PDO线促进胶原合成，但研究主要针对PDO线功能改善，而非直接评估积雪草苷的抗皱功效，且混杂其他成分。
The abstract showed that asiaticoside-coated PDO threads promoted collagen synthesis, but the study mainly focused on improving PDO thread function, not directly evaluating the anti-wrinkle efficacy of asiaticoside, and was confounded by other components.
摘要显示积雪草提取物在50 mg/mL时促进胶原合成，但未明确分离积雪草苷单独作用，且抗皱功效仅间接通过胶原合成推断，未直接测量皱纹改善。
The abstract showed that Centella asiatica extract promoted collagen synthesis at 50 mg/mL, but did not isolate the effect of asiaticoside alone, and anti-wrinkle efficacy was only indirectly inferred from collagen synthesis without direct measurement of wrinkle improvement.
摘要仅研究积雪草苷的控释特性，未涉及抗皱功效或相关生物活性。
The abstract only studied the controlled release properties of asiaticoside, without involving anti-wrinkle efficacy or related biological activity.
摘要仅提及积雪草苷通过促进成纤维细胞增殖和胶原合成等机制改善光老化皮肤，但未提供直接实验数据支持抗皱功效。
The abstract only mentioned that asiaticoside improves photoaged skin by promoting fibroblast proliferation and collagen synthesis, but did not provide direct experimental data supporting anti-wrinkle efficacy.
摘要研究积雪草苷促进伤口愈合，而非抗皱功效，且未涉及皱纹相关指标。
The abstract studied asiaticoside promoting wound healing, not anti-wrinkle efficacy, and did not involve wrinkle-related indicators.
篇数为本站收录的公开文献数，不同功效之间不可直接比较强弱 —— 研究热度受行业投入影响，与成分实际表现无关。
排序依据是本站收录的公开文献篇数，只反映研究数量、不代表功效强弱，也不是选料建议。
本站收录 8 篇与「抗皱」相关的公开发表研究，年份跨度 2011–2025；其中人体临床研究 0 篇。逐篇的研究类型与结论解读见本页「文献逐条」。
不能。中国现行法规要求功效宣称依据按《化妆品功效宣称评价规范》以人体功效评价试验、消费者使用测试或实验室试验等规定方式取得，文献综述仅在特定情形下可用。本页只是公开文献的整理，不构成宣称依据。
按原研究作者自身的结论归类：支持 0 篇、结论不一 5 篇、未观察到效果或结论相反 1 篇、仅机制探讨 2 篇。结论不完全一致，阅读时请结合各研究的研究类型与试验条件。
国家药监局备案数据中，含积雪草苷且宣称「抗皱」的产品有 4,399 个，占该成分全部备案产品的 20.21%，相对全市场的富集度 lift 为 2.014。共现是市场统计上的相关性，不代表该成分对该功效有贡献。
是否收录于《已使用化妆品原料目录》、以及各法域的限量与使用范围，见积雪草苷的成分档案页；本页只整理与「抗皱」相关的文献证据，不含法规限值。